Cosegregation analysis following an excellent response to olaparib in a pancreatic cancer patient carrier of BRCA2:c.7892 T > C variant enables its reclassification from VUS to pathogenic.
- DOI
- 10.1038/s44276-026-00206-0
- Published
- 2026 Feb 16
- Container
- BJC reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s44276-026-00206-0,
title = {Cosegregation analysis following an excellent response to olaparib in a pancreatic cancer patient carrier of BRCA2:c.7892 T > C variant enables its reclassification from VUS to pathogenic.},
author = {Strojnik K and Blatnik A and Krajc M and Novaković A and Ignjatović M and Ocvirk J and Stegel V and Škerl P and Klančar G and Novaković S and Šetrajčič Dragoš V},
year = {2026},
journal = {BJC reports},
doi = {10.1038/s44276-026-00206-0},
url = {https://doi.org/10.1038/s44276-026-00206-0}
}RIS
TY - JOUR TI - Cosegregation analysis following an excellent response to olaparib in a pancreatic cancer patient carrier of BRCA2:c.7892 T > C variant enables its reclassification from VUS to pathogenic. AU - Strojnik K AU - Blatnik A AU - Krajc M AU - Novaković A AU - Ignjatović M AU - Ocvirk J AU - Stegel V AU - Škerl P AU - Klančar G AU - Novaković S AU - Šetrajčič Dragoš V PY - 2026 JO - BJC reports DO - 10.1038/s44276-026-00206-0 UR - https://doi.org/10.1038/s44276-026-00206-0 ER -
APA
K, S., A, B., M, K., A, N., M, I., J, O., V, S., P, Š., G, K., S, N., & V, Š. D. (2026). Cosegregation analysis following an excellent response to olaparib in a pancreatic cancer patient carrier of BRCA2:c.7892 T > C variant enables its reclassification from VUS to pathogenic.. BJC reports. https://doi.org/10.1038/s44276-026-00206-0
Source records
- pubmed · retrieved 2026-09-27T10:51:33.198Z